Education
About Us
Working with TipRanks
Follow Us
Tianda Pharmaceuticals Ltd. (HK:0455)
:0455
Total Valuation
Tianda Pharmaceuticals Ltd. has a market cap or net worth of HK$354.76M. The enterprise value is HK$671.54M.
Market CapHK$354.76M
Enterprise ValueHK$671.54M
Share Statistics
Tianda Pharmaceuticals Ltd. has 2,150,041,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,150,041,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tianda Pharmaceuticals Ltd.’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -4.00%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-4.00%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee759.04K
Profits Per Employee-34.46K
Employee Count701
Asset Turnover0.58
Inventory Turnover4.25
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio0.66
Price to Fair Value0.79
Price to FCF-35.65
Price to Operating Cash Flow26.92
PEG Ratio-2.61
Income Statement
In the last 12 months, Tianda Pharmaceuticals Ltd. had revenue of 532.09M and earned -24.16M in profits. Earnings per share was -0.01.
Revenue532.09M
Gross Profit255.53M
Operating Income-29.02M
Pretax Income-25.69M
Net Income-24.16M
EBITDA15.66M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -26.10M and capital expenditures -16.97M, giving a free cash flow of -43.08M billion.
Operating Cash Flow-26.10M
Free Cash Flow-43.08M
Free Cash Flow per Share-0.02
Dividends & Yields
Tianda Pharmaceuticals Ltd. pays an annual dividend of HK$0.002, resulting in a dividend yield of 3.15%
Dividend Per ShareHK$0.002
Dividend Yield3.15%
Payout Ratio-6.90%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change-34.62%
50-Day Moving Average0.15
200-Day Moving Average0.17
Relative Strength Index (RSI)75.15
Average Volume (3m)71.00K
Important Dates
Tianda Pharmaceuticals Ltd. upcoming earnings date is Nov 28, 2025, TBA (Not Confirmed).
Last Earnings DateMar 28, 2025
Next Earnings DateNov 28, 2025
Ex-Dividend DateJun 13, 2024
Financial Position
Tianda Pharmaceuticals Ltd. as a current ratio of 1.10, with Debt / Equity ratio of 0.00%
Current Ratio1.10
Quick Ratio0.89
Debt to Market Cap0.22
Net Debt to EBITDA-3.12
Interest Coverage Ratio-5.87
Taxes
In the past 12 months, Tianda Pharmaceuticals Ltd. has paid -689.00K in taxes.
Income Tax-689.00K
Effective Tax Rate0.03
Enterprise Valuation
Tianda Pharmaceuticals Ltd. EV to EBITDA ratio is 26.81, with an EV/FCF ratio of -3.62.
EV to Sales0.79
EV to EBITDA26.81
EV to Free Cash Flow-3.62
EV to Operating Cash Flow-8.44
Balance Sheet
Tianda Pharmaceuticals Ltd. has HK$103.77M in cash and marketable securities with HK$98.81M in debt, giving a net cash position of -HK$4.95M billion.
Cash & Marketable SecuritiesHK$103.77M
Total DebtHK$98.81M
Net Cash-HK$4.95M
Net Cash Per Share>-HK$0.01
Tangible Book Value Per ShareHK$0.23
Margins
Gross margin is 80.47%, with operating margin of -5.45%, and net profit margin of -4.54%.
Gross Margin80.47%
Operating Margin-5.45%
Pretax Margin-4.83%
Net Profit Margin-4.54%
EBITDA Margin2.94%
EBIT Margin-3.90%
Analyst Forecast
The average price target for Tianda Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―